Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Comparing SMILE and SMILE Xtra procedures for myopia treatment

Official title: A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia

Run by Shanghai Zhongshan Hospital · NCT06992011 · Data updated 2026-11-12

This study is testing which of two eye surgeries, SMILE or SMILE Xtra, works better for treating nearsightedness and keeping your vision stable.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment300 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedMay 28, 2025
Trial IDNCT06992011 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-50 with moderate myopia and stable vision over the past two years.

Probably not a fit

Patients with other eye diseases or those who have had prior ocular surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two surgical procedures, SMILE and SMILE Xtra, in treating myopia. It aims to compare their clinical efficacy, biomechanical stability, and optical quality through a randomized controlled approach. Participants will be monitored for visual outcomes and any potential complications associated with each procedure.

Why it matters

Potential benefit: If successful, this study could provide patients with improved options for myopia correction with potentially better visual outcomes.

How similar studies have gone: Previous studies have shown promising results with SMILE procedures, indicating potential for success in this comparative approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-50 years
2. MRSE (Manifest Refraction Spherical Equivalent) -6.00D to -10.00D with refractive changes within ±0.50D in past 2 years
3. CDVA (Corrected Distance Visual Acuity) ≥ 20/25
4. Myopia progression ≤ 0.50D/year for ≥2 years
5. RST (Residual Stromal Thickness) ≥ 250μm after lenticule removal
6. Contact lens discontinuation as per protocol

Exclusion Criteria:

1. Other eye diseases (keratoconus, glaucoma, etc.)
2. Corneal scarring, cataracts affecting observation
3. Systemic diseases affecting surgery compliance
4. Prior ocular surgeries
5. Pregnancy, breastfeeding, or menstruation
6. Drug allergies to surgical medication

Where it's running

  • Zhongshan Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.